Synthetic oligodeoxynucleotide containing CpG motif induces an anti-polysaccharide type 1-like immune response after immunization of mice with Haemophilus influenzae type b conjugate vaccine

International Immunology

Volumn 12, Issue 3, 2000, Pages 295-303

  Von Hunolstein, Christina ^a   Teloni, Raffaela ^a   Mariotti, Sabrina ^a   Recchia, Simona ^a   Orefici, Graziella ^a   Nisini, Roberto ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Hib conjugate vaccine; Immunostimulatory sequences; Polysaccharide; Type 1 immune response

Indexed keywords

CARRIER PROTEIN; DIPHTHERIA TOXOID; FREUND ADJUVANT; GAMMA INTERFERON; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G3; IMMUNOLOGICAL ADJUVANT; IMOVAX TETANO; INTERLEUKIN 12; OLIGODEOXYNUCLEOTIDE; POLYSACCHARIDE; TETANUS TOXOID; UNCLASSIFIED DRUG; VAXEMHIB; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; CPG ISLAND; CYTOKINE RELEASE; FEMALE; HAEMOPHILUS INFLUENZAE TYPE B; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS IMMUNITY;

HAEMOPHILUS INFLUENZAE;

EID: 0034006047     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/12.3.295     Document Type: Article

References (34)

1. Mond, J. J., Lees, A. and Snapper, C. M. 1995. T cell-independent antigens type 2. Annu. Rev. Immunol. 13:655.
2. Peltola, H., Käyhty, H., Sivonen, A. and Mäkelä, P. H. 1977. Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100 000 vaccinees 3 months to 5 years of age in Finland. Pediatrics. 60:730.
3. Anderson, P. 1983. Antibody responses to Haemophilus influenza type b and diphtheria toxin induced by conjugates of oligosaccharides of the type b capsule with the nontoxic protein CRM197. Infect. Immun. 39:233.
4. Schneerson, R., Barrera, O., Sutton, A. and Robbins, J. D. 1980. Preparation, characterization and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugated. J. Exp. Med. 152:361.
5. Abbas, A. K., Murphy, K. M. and Sher, A. 1996. Functional diversity of helper T lymphocytes. Nature 383:787.
6. + T cells. Annu. Rev. Immunol. 12:635.
7. Roman, M., Martin-Orozco, E., Goodman, J. S., Nguyen, M. D., Sato, Y., Ronaghy, A., Kornbluth, R. S., Richman, D. D., Carson, D. A. and Raz, E. 1997. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat. Med. 3:849.
8. Klinman, D. M., Yi, A. K., Beaucage, S. L., Conover, J. and Krieg, A. M. 1996. CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon γ. Proc. Natl Acad. Sci. USA 93:2879.
9. Yamamoto, S., Yamamoto, T., Shimada, S., Kuramoto, E., Yano, O., Kataoka, T. and Tokunaga, T. 1992. DNA from bacteria, but not from vertebrates induces interferons, activates Natural Killer cells and inhibits tumor growth. Microbiol. Immunol. 36:983.
10. Pisetsky, D. S. 1996. Immune activation by bacterial DNA: a new genetic code. Immunity 5:303.
11. h1) immunity. J. Exp. Med. 186:1623.
12. Sun, S., Kishimoto, H. and Sprent, J. 1998. DNA as an adjuvant: capacity of insect DNA and synthetic oligodeoxynucleotides to augment T cell responses to specific antigen. J. Exp. Med. 187:1145.
13. Threadgill, D. S., McCormick, L. L., McCool, T. L., Greenspan, N. S. and Schreiber, J. R. 1998. Mytogenic synthetic polynucleotides suppress the antibody response to a bacterial polysaccharide. Vaccine 16:76.
14. Murphy, T. V., White, K. E., Pastor, P., Gabriel, L., Medley, F., Granoff, D. M. and Osterholm, M. T. 1993. Declining incidence of Haemophilus influenzae type b disease since introduction of vaccination. J. Am. Med. Ass. 269:246.
15. Fagiolo, A., Amadori, A., Biselli, R., Paganelli, R., Nisini, R., Cozzi, E., Zamardini, R. and D'Amelio, R. 1993. Quantitative and qualitative analysis of anti-tetanus toxoid antibody response in the elderly. Humoral immune response enhancement by thymostimulin. Vaccine 11:1336.
16. Pertmer, T. M., Roberts, T. R. and Haynes, J. R. 1996. Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J. Virol. 70:6119.
17. Krieg, A. M. 1996. Lymphocyte activation by CpG dinucleotide motifs in prokaryotic DNA. Trends Microbiol. 4:73.
18. h1 responses by immunostimulatory DNA. J. Immunol. 28:2045.
19. Germann, T., Bongartz, M., Dlugonska, H., Hess, H., Schmitt, E., Kolbe, L., Kölsch, E., Podlaski, F. J., Gatley, M. K. and Rüde, E. 1995. Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo. Eur. J. Immunol. 25:823.
20. Finkelman, F. D., Holmes, J., Katona, I. M., Urban, J. F., Beckmann, M. P., Park, L. S., Schooley, K. A., Coffman, R. L., Mosmann, T. R. and Paul, W. E. 1990. Lymphokine control of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol. 8:303.
21. Ruzek, M. C., Miller, A. H., Opal, S. M., Pearce, B. D. and Biron, C. A. 1997. Characterization of early cytokine responses and an Interleukine (IL)-6-dependent pathway of endogenous glucocorticoid induction during murine cytomegalovirus infection. J. Exp. Med. 185:1185.
22. Yi, A. E., Klinmann, D. M., Martin, T. L., Matson, S. and Krieg, A. M. 1966. Rapid immune activation by CpG motifs in bacterial DNA. Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway. J. Immunol. 157:5394.
23. Zhao, Q., Temsamani, J., Zhou, R. Z. and Agrawal, S. 1997. Pattern and kinetics of cytokine production following administration of phosphorothioate oligonucleotides in mice. Antisense Nucleic Acids Drug Dev. 7:495.
24. Martin-Orozco, E., Kobayashi, H., Van Uden, J., Nguyen, M.-D., Kornbluth, R. S. and Raz, E. 1999. Enhancement of antigen-presenting cell surface molecules involved in cognate interactions by immunostimulatory DNA sequences. Int. Immunol. 11:1111.
25. Lanzavecchia, A. 1987. Antigen uptake and accumulation in antigen-specific B cells. Immunol. Rev. 99:39.
26. h2 immunity in neonatal mice. Science 271:1728.
27. Dullforce, P., Sutton, D. C. and Heath, A. W. 1998. Enhancement of T cell-independent immune responses in vivo by CD40 antibodies. Nat. Med. 4:88.
28. Hocart, M. J., Mackenzie, J. S. and Stewart, J. A. 1989. The IgG subclass responses to Influenza virus haemagglutinin in the mouse: effect of route of inoculation. J. Gen. Virol. 70:809.
29. Sallusto, F. and Lanzavecchia, A. 1999. Mobilizing dendritic cells for tolerance, priming, and chronic inflammation. J. Exp. Med. 189:611.
30. Lanzavecchia, A. Reid, P.A. and Watts, C. 1992. Irreversible association of peptides with class II MHC molecules in living cells. Nature 357:249.
31. Shams, H. and Heron, I. 1998. The effect of conjugation on immunogenicity and potency of protein carriers of polyribosylribitol phosphate (PRP) conjugated vaccines in mouse model. APMIS 106:526.
32. Claesson, B. A., Trollfors, B., Lagergård, T., Taranger, J., Bryla, D., Otterman, G., Cramton, T., Yang, Y., Reimer, C. B. Robbins, J. B. and Schneerson, R. 1988. Clinical and immunologic response to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18 to 23 month-old children. J. Pediatr. 112:695.
33. Carlsson, R. M., Claesson, B. A., Iwarson, S., Lagergård, T. and Käyhty, H. 1994. Antibodies against Haemophilus influenzae type b and tetanus in infants after subcutaneous vaccination with PRP-T/diphtheria, or PRP-OMB/diphtheria-tetanus vaccines. Pediatr. Infect. Dis. J. 13:27.
34. Carlsson, R. M., Claesson, B. A., Lagergård, T. and Käyhty, H. 1996. Serum antibodies against Haemophilus influenzae type b and tetanus at 2.5 years of age: a follow-up of 2 different regimens of infant vaccination. Scand. J. Infect. Dis. 28:519.